Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M04NM11 dose-escalation placebo-controlled study in chronic hepatitis B
2005-005293-70Phase 2Completed
- Sponsor
- Emergent BioSolutions
- Start
- Mar 2006
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of M04NM11 in hepatitis B (HBV), sponsored by Emergent BioSolutions. Started Mar 2006; status: completed.
02
Drugs
M04NM11
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2005-005293-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005293-70.